Uploaded December 2025 | Updated September 2026, 2 weeks ago
Ned Steele calls Pluvicto® a "miracle drug." Diagnosed with metastatic prostate cancer in 2011, he's seen his share of treatments. When options were becoming limited for him, Duke Health's Daniel Geroge, MD, a medical oncologist and prostate cancer specialist, put him on Pluvicto. Steele's PSA plummeted. Not only did the treatment shrink his tumors, it also came with very few side effects, unlike typical treatments for cancer like chemotherapy and radiation.
Pluvicto is a type of radiotheranostic treatment - an area that Duke experts are helping to propel forward, looking for new ways to treat cancer.
00:00 Intro
00:17 What are radiotheranostics for cancer?
01:05 What are the benefits of Pluvicto and other radiotheranostics?
1:25: How does Pluvicto work?
02:19 What are the pros and cons of Pluvicto?
Ned Steele calls Pluvicto® a "miracle drug." Diagnosed with metastatic prostate cancer in 2011, he's seen his share of treatments. When options were becoming limited for him, Duke Health's Daniel Geroge, MD, a medical oncologist and prostate cancer specialist, put him on Pluvicto. Steele's PSA plummeted. Not only did the treatment shrink his tumors, it also came with very few side effects, unlike typical treatments for cancer like chemotherapy and radiation.
Pluvicto is a type of radiotheranostic treatment - an area that Duke experts are helping to propel forward, looking for new ways to treat cancer.
00:00 Intro
00:17 What are radiotheranostics for cancer?
01:05 What are the benefits of Pluvicto and other radiotheranostics?
1:25: How does Pluvicto work?
02:19 What are the pros and cons of Pluvicto?
